Literature DB >> 20492605

A functional AQP1 allele producing a Co(a-b-) phenotype revises and extends the Colton blood group system.

Lionel Arnaud1, Virginie Helias, Cécile Menanteau, Thierry Peyrard, Nicole Lucien, Pierre Ripoche, Régine Lapègue, Bach-Nga Pham, Pierre-Yves Le Pennec, John J Moulds, Jean-Pierre Cartron.   

Abstract

BACKGROUND: The Colton blood group system currently comprises three antigens, Co(a) , Co(b) , and Co3. The latter is only absent in the extremely rare individuals of the Colton "null" phenotype, usually referred to as Co(a-b-), which lack the water channel AQP1 that carries the Colton antigens. The discovery of a Co(a-b-) individual with no AQP1 deficiency suggested another molecular basis for the Co(a-b-) phenotype. STUDY DESIGN AND METHODS: Red blood cells were analyzed by stopped-flow light scattering and Western blotting and typed by hemagglutination and flow cytometry. Genotyping by sequencing and polymerase chain reaction-restriction fragment length polymorphism was applied. An expression system for Colton antigens was developed in mammalian cells.
RESULTS: Although Co(a-b-), the proband expressed fully functional AQP1 and had developed a novel Colton alloantibody. Sequencing of AQP1 revealed a homozygous nucleotide change (140A>G) encoding the single-amino-acid substitution Q47R. A second case was identified due to the presence of this novel Colton alloantibody. By generating an expression system for Colton antigens in K-562 cells, the Q47R substitution was shown to inhibit the expression of both Co(a) and Co(b) antigens. Other naturally occurring single-amino-acid substitutions, that is, A45T, P38L, and N192K, were also studied in this Colton antigen expression system.
CONCLUSIONS: The Co(a-b-) phenotype can be generated by a functional AQP1 allele, that is, AQP1 140G encoding AQP1 (Q47R) and allowing the development of a novel Colton alloantibody. This study also shows that the Co(b) antigen can be produced by at least two different substitutions at Amino Acid Position 45, that is, A45V and A45T.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20492605     DOI: 10.1111/j.1537-2995.2010.02687.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  The AQP1 mutation c.601delG causes the Co-negative phenotype in four patients belonging to the Romani (Gypsy) ethnic group.

Authors:  Brigitte K Flesch; Burkhard Just; Robert Deitenbeck; Angelika Reil; Jürgen Bux; Núria Nogués; Eduardo Muñiz-Diaz
Journal:  Blood Transfus       Date:  2013-10-18       Impact factor: 3.443

2.  A new AQP1 null allele identified in a Gypsy woman who developed an anti-CO3 during her first pregnancy.

Authors:  C Saison; T Peyrard; C Landre; B A Ballif; K A Schlosser; I Dettori; C Chicheportiche; P Nemeth; J-P Cartron; L Arnaud
Journal:  Vox Sang       Date:  2012-02-20       Impact factor: 2.144

3.  International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report.

Authors:  J R Storry; L Castilho; G Daniels; W A Flegel; G Garratty; C L Francis; J M Moulds; J J Moulds; M L Olsson; J Poole; M E Reid; P Rouger; E van der Schoot; M Scott; E Smart; Y Tani; L-C Yu; S Wendel; C Westhoff; V Yahalom; T Zelinski
Journal:  Vox Sang       Date:  2011-03-14       Impact factor: 2.144

4.  Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.

Authors:  Randall W Velliquette; Kim Hue-Roye; Christine Lomas-Francis; Barbara Gillen; Jennifer Schierts; Kristie Gentzkow; Thierry Peyrard; Inge von Zabern; Willy A Flegel; Karen Rodberg; Asim K Debnath; Soohee Lee; Marion E Reid
Journal:  Transfusion       Date:  2013-04-08       Impact factor: 3.157

Review 5.  Transfusion Medicine and Molecular Genetic Methods.

Authors:  Rozieyati Mohamed Saleh; Zulkafli Zefarina; Nor Fazila Che Mat; Geoffrey Keith Chambers; Hisham Atan Edinur
Journal:  Int J Prev Med       Date:  2018-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.